NN

Nunsavat Naik Vamsi Krishna

Director Additional Director DIN 06454065
DIN 06454065 First appointment Dec 2012 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 1 historical roles
Total affiliations 1 Since Dec 2012
Shareholding value β€’β€’β€’β€’ Premium profile

About Nunsavat Naik Vamsi Krishna

Data last updated:

Nunsavat Naik Vamsi Krishna was an Additional Director at Spenmarks Pharma Private Limited (2012–2013). The company operates in Chemicals.

DIN 06454065
Primary Designation Additional Director
Industry Chemicals
First Appointment 19 Dec 2012

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Spenmarks Pharma Private Limited U24100TG2009PTC066264
Additional Director19 Dec 20122009Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Spenmarks Pharma Private Limited
Premium access

Shareholding and investment profile for Nunsavat Naik Vamsi Krishna

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nunsavat Naik Vamsi Krishna

Nunsavat Naik Vamsi Krishna was first appointed on 19 Dec 2012 as Additional Director at Spenmarks Pharma Private Limited.

Nunsavat Naik Vamsi Krishna held 1 earlier board appointment: Spenmarks Pharma Private Limited (Additional Director, 19 Dec 2012 to 20 Jul 2013).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available